Treatment of Indolent and Advanced Systemic Mastocytosis

Castells M, Butterfield J

J Allergy Clin Immunol Pract · 2022

Key Findings

  • Stepwise treatment: H1/H2 antihistamines, cromolyn, leukotriene antagonists, then cytoreductive therapy
  • Anaphylaxis prevention paramount in ISM management

Referenced in (1 disease)

Validation history

Full log →
  1. passsource metadataJun 1, 2026, 04:40 PMby pubmed-api

    Stored DOI was incorrect; corrected to the PubMed-registered DOI (verified to resolve to this article).

    tools: pubmed.esummary, crossref.works

ID: pmid-35615325DOI: 10.4084/MJHID.2022.040PMID: 35615325